Cullinan Therapeutics, Inc. (CGEM) — DEFA14A Filings
All DEFA14A filings from Cullinan Therapeutics, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Cullinan Therapeutics Files DEFA14A Proxy Materials
— Apr 28, 2026 Risk: low
Cullinan Therapeutics, Inc. filed a Definitive Additional Materials (DEFA14A) on April 28, 2026. The filing, with SEC Accession Number 0001193125-26-183472, con
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX